Fentanyl Citrate Injection · #2 of 35 active shortages by FDA posting duration
Brand: FENTANYL CITRATE
FDA lists Fentanyl Citrate Injection as Active Shortage (Fresenius Kabi USA, LLC).
Availability on file: Unavailable
Fentanyl Citrate Injection: Active Shortage
Unavailable 19 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Fentanyl Citrate Injection
- Manufacturer
- Fresenius Kabi USA, LLC
- Dosage Form
- Injection
- Presentation
- Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)
- Package NDC
- 63323-806-20
Status & Timeline
- Status
- Active Shortage
- Availability
- Unavailable
- First Reported
- Jan 1, 2012
- Last Updated
- Mar 17, 2026
- Therapeutic Category
- Analgesia/Addiction, Pediatric
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Next release not available at this time. Check wholesalers for inventory.
Full Drug Profile
fentanyl
Side effects, interactions, warnings & more
Nearby, Other Fentanyl Shortage Records
Fentanyl Citrate Injection
Fresenius Kabi USA, LLC
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
Fentanyl Citrate Injection
Hospira, Inc., a Pfizer Company
Injection
FDA reason on file: Next release not available at this time. General shortage guidance lives on the tracker hub.